psalexa
logo

Microscopic Polyangiitis Therapeutics Pipeline Analysis

Microscopic Polyangiitis Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Delivery : 1-2 Working Days
Report Code: LS11282
Available Format:

Microscopic polyangiitis is an inflammatory disorder that leads to the damage of organs such as kidneys, lungs, skin, joints, and nerves. The disease can be symptomatized by weight loss, inflammation of the kidneys, skin lesions, fever, nerve damage, skin rash, muscle and joint pain, loss of sensation, seizures, abdominal pain, and cough. However, the cause of microscopic polyangiitis is unknown, but it is thought that the overactive immune system causes the inflammation in the tissues and blood vessels. The Chiba University is in the process of developing glucocorticoids for the treatment of microscopic polyangiitis. ChemoCentryx, Inc. is also in the process of developing avacopan (CCX168) as a C5a receptor antagonist for the treatment of microscopic polyangiitis. Some of the companies having the pipeline of microscopic polyangiitis include Amgen plc, ChemoCentryx, Inc., and others.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 3250
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 4000
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7750

Pre-Purchase Enquiry